Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Stayble Therapeutics AB

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 238 Less Arrow 28 More Arrow 57
Earnings before taxes -23,737 Less Arrow -24,526 More Arrow -12,090
EBITDA -23,954 Less Arrow -24,796 More Arrow -12,132
Total assets 21,703 Less Arrow 19,148 More Arrow 43,639
Current assets 16,053 Less Arrow 13,498 More Arrow 37,989
Current liabilities 4,345 Less Arrow 3,016 Less Arrow 2,981
Equity capital 16,508 Less Arrow 15,282 More Arrow 39,808
- share capital 4,124 Less Arrow 1,800 Equal arrow 1,800
Employees (average) 3 Equal arrow 3 Equal arrow 3

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 76.1% More Arrow 79.8% More Arrow 91.2%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -108.3% Less Arrow -127.9% More Arrow -27.6%
Current ratio 369.5% More Arrow 447.5% More Arrow 1274.4%
Return on equity (ROE) -143.8% Less Arrow -160.5% More Arrow -30.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Equal arrow 0 More Arrow 1
Chg. No. of employees % 0% Equal arrow 0% More Arrow 50%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.